Spero Therapeutics (SPRO US)

Spero Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on identifying, developing, and commercializing novel treatments for MDR bacterial infections. Spero Therapeutics also offers a technology platform that develops drugs to expand the spectrum and potency of existing antibiotics. Spero Therapeutics serves customers worldwide.